Brain-selective Kinase 2 (BRSK2) Phosphorylation on PCTAIRE1 Negatively Regulates Glucose-Stimulated Insulin Secretion in Pancreatic Β-Cells.

Xin-Ya Chen,Xiu-Ting Gu,Hexige Saiyin,Bo Wan,Yu-Jing Zhang,Jing Li,Ying-Li Wang,Rui Gao,Yu-Fan Wang,Wei-Ping Dong,Sonia M. Najjar,Chen-Yu Zhang,Han-Fei Ding,Jun O. Liu,Long Yu
DOI: https://doi.org/10.1074/jbc.m112.375618
2012-01-01
Abstract:Brain-selective kinase 2 (BRSK2) has been shown to play an essential role in neuronal polarization. In the present study, we show that BRSK2 is also abundantly expressed in pancreatic islets and MIN6 β-cell line. Yeast two-hybrid screening, GST fusion protein pull-down, and co-immunoprecipitation assays reveal that BRSK2 interacts with CDK-related protein kinase PCTAIRE1, a kinase involved in neurite outgrowth and neurotransmitter release. In MIN6 cells, BRSK2 co-localizes with PCTAIRE1 in the cytoplasm and phosphorylates one of its serine residues, Ser-12. Phosphorylation of PCTAIRE1 by BRSK2 reduces glucose-stimulated insulin secretion (GSIS) in MIN6 cells. Conversely, knockdown of BRSK2 by siRNA increases serum insulin levels in mice. Our results reveal a novel function of BRSK2 in the regulation of GSIS in β-cells via a PCTAIRE1-dependent mechanism and suggest that BRSK2 is an attractive target for developing novel diabetic drugs.
What problem does this paper attempt to address?